Home > Healthcare > Medical Devices > Therapeutic Devices > Vaginal Slings Market

Vaginal Slings Market Trends

Report ID: GMI3335
Published Date: Jan 2024
Report Format: PDF

Download Free Sample

Vaginal Slings Market Trends

The continuous technological advancements in surgical techniques, rising emphasis on personalized medicine, and surging demand for integrated AI in healthcare delivery will favor the market growth. Lately, a transition towards patient-centered treatment has been observed in the healthcare landscape. Physicians are placing focus on recognizing and meeting the unique requirements and preferences of patients having vaginal sling operations. This has made way for shared decision-making, informed consent, and continual communication to improve patient satisfaction.

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

Vaginal slings market size crossed USD 1.6 billion in 2023 and is expected to register 9% CAGR from 2024-2032 owing to the rising prevalence of stress urinary incontinence (SUI), and the strong demand for minimally invasive procedures worldwide.

Vaginal slings industry from the transobturator slings segment is expected to register 8.5% CAGR from 2024-2032 due to patients often preferring minimally invasive procedures over traditional open surgical techniques.

North America vaginal slings industry reached over USD 385 million in 2023 and is expected to register 8.6% CAGR from 2024-2032 due to ongoing advancements in surgical techniques, materials, and design of vaginal slings in the region.

UroCure, B. Braun, Melsungen AG, Betatech Medical, Boston Scientific Corporation, Caldera Medical, Coloplast Corp, Cousin Surgery, Johnson & Johnson Services, Inc., Lotus Surgicals, Neomedic International, and Promedon S.A., are some of the major vaginal slings companies worldwide.